BioSpace News Archive

PDS Biotechnology Corporation (“PDS Biotech” or the “Company”) (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® T-cell activating technology, today announced the pricing of its previously announced underwritten public offering consisting of 6,000,000 shares of common stock at a public offering price of $2.75 per share. The

Medly Continues Nationwide Expansion With the Launch of Digital Pharmacy Services, Including Free, Same-Day Delivery, Into the Baltimore Market

Eisai Inc., an oncology- and neurology-focused pharmaceutical company and the U.S. subsidiary of Eisai Co., Ltd., (based in Tokyo, Japan) announced today the relocation of its New Jersey-based headquarters to the technologically-advanced and cutting-edge ON3 (www.on3nj.com) property in Nutley, New Jersey.

Promega Corporation today announced the launch of its new serological antibody test for COVID-19 to detect the presence of antibodies against the SARS-CoV-2 virus

Altitude Lab announced its first resident companies and opened applications for its breakthrough collaborative facility and program. Founded by Recursion and the University of Utah’s Center for Technology & Venture Commercialization (TVC), the incubator fills the critical role of finding, supporting, incubating and accelerating early-stage life science and health care companies in Utah.

Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its common shares listed in the United States, under the symbol APLIF, are Depository Trust Company (DTC) eligible. DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today provided an overview of the process to report the final results from the acceptance period of its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), which expired at 24:00 hours ( Frankfurt am M

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman and Chief Executive Officer, Kevin Hrusovsky, will participate in a virtual fireside chat discussion at the Canaccord Genuity 40th Annual Growth Conference

Expands Consumer Self-Care International’s (“CSCI”) robust dermatology platform into growing geographies with market-leading, margin accretive brands Leverages CSCI’s best-in-class skincare competencies and full product pipeline to drive future revenue synergies

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces a co-marketing and equipment loan agreement with Agilent Technologies Inc. to support development of integrated iCIEF-MS assays by interfacing Intabio’s Blaze